Clinical trial

The AutoloGel™ Post-Market Surveillance (TAPS) Program

NCT00762138

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-09-01

PhaseNA

Study timeline

Study start (unknown)2008-09-01Date precision: month

Registry last updated2014-02-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Woundsunresolved

Leg Ulcersunresolved

Pressure Ulcersunresolved

Diabetic Foot Ulcersunresolved

Interventions

AutoloGel SystemDEVICE

Sponsors & collaborators

Cytomedixlead sponsor

CTI Clinical Trial and Consulting Servicescollaborator

Mapped research locations

AugustaGeorgia, United States1 El PasoTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00762138 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.